Effect of Jingui Shenqiwan Combined with Fracture Three-stage Syndrome Differentiation on Recovery of Patients with Osteoporotic Vertebral Compression Fractures After Operation

Bao-ming TANG; Zhao-wei LI; Ai-rong YANG; Zhuo-ya WANG

doi:10.13422/j.cnki.syfjx.20200832

您当前的位置：

首页 >

文章列表页 >

Effect of Jingui Shenqiwan Combined with Fracture Three-stage Syndrome Differentiation on Recovery of Patients with Osteoporotic Vertebral Compression Fractures After Operation

Clinic | 更新时间：2020-09-16

- Effect of Jingui Shenqiwan Combined with Fracture Three-stage Syndrome Differentiation on Recovery of Patients with Osteoporotic Vertebral Compression Fractures After Operation
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 20, Pages: 105-110(2020)
- 作者机构：
  
  青海大学附属医院，西宁 810001
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20200832
  CLC： R289;R68;R681;R681.5
- Received：08 April 2020，
  
  Published Online：28 May 2020，
  
  Published：20 October 2020
- 稿件说明：
移动端阅览
唐保明,李钊伟,杨爱荣等.金匮肾气丸结合骨折三期辨证对骨质疏松性椎体压缩性骨折术后康复的影响[J].中国实验方剂学杂志,2020,26(20):105-110.

TANG Bao-ming,LI Zhao-wei,YANG Ai-rong,et al.Effect of Jingui Shenqiwan Combined with Fracture Three-stage Syndrome Differentiation on Recovery of Patients with Osteoporotic Vertebral Compression Fractures After Operation[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(20):105-110.
唐保明,李钊伟,杨爱荣等.金匮肾气丸结合骨折三期辨证对骨质疏松性椎体压缩性骨折术后康复的影响[J].中国实验方剂学杂志,2020,26(20):105-110. DOI： 10.13422/j.cnki.syfjx.20200832.

TANG Bao-ming,LI Zhao-wei,YANG Ai-rong,et al.Effect of Jingui Shenqiwan Combined with Fracture Three-stage Syndrome Differentiation on Recovery of Patients with Osteoporotic Vertebral Compression Fractures After Operation[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(20):105-110. DOI： 10.13422/j.cnki.syfjx.20200832.

摘要

目的

评价金匮肾气丸结合骨折三期辨证治疗骨质疏松性椎体压缩性骨折（OVCF）术后的近期和远期疗效及对骨代谢标志物的调节作用。

方法

将135例OVCF术后患者按随机数字表法分为对照组67和观察组68例。对照组脱落4例，失访2例，剔除3例，完成58例，观察组分别为3例，2例和3例，完成60例。两组均采用依降钙素注射液，20单位/次，肌肉注射，1次/1周，共12周；口服碳酸钙D3咀嚼片(Ⅱ)，1片/次，2次/d；阿仑膦酸钠片，70 mg/次，1次/周。对照组口服补肾健骨胶囊，4粒/次，3次/d；观察组采用金匮肾气丸加减并结合骨折三期辨证内服，1剂/d；两组均连续治疗24周，并进行24周随访。近期疗效指标包括腰背疼痛、腰椎功能、中医证候和并发症情况，分别于术前、术后12周和24周各评价1次；远期疗效包括责任椎体恢复情况、腰椎功能、骨密度、生活质量和48周再骨折发生率；检测前后骨碱性磷酸酶(BALP)，骨钙素(BGP)，抗酒石酸酸性磷酸酶-5b(TRAP-5b)，Ⅰ型胶原羧基端前肽(PICP)，Ⅰ型胶原交联C端肽(

-CTX)和

端中段骨钙素(

-MID-OT)水平；进行安全性评价。

结果

观察组综合疗效优于对照组（

＝2.026，

0.05）；观察组在术后12，24周的腰背疼痛、腰椎功能和中医证候评分均低于对照组（

0.01），继续观察显示观察组在术后48周腰椎功能评分也低于对照组（

0.01）；观察组在术后24，48周L

1-4

骨密度高于对照组，生活质量评分低于对照组（

0.01）；观察组在术后24，48周Cobb角均小于对照组，责任椎体高度（前缘、中央、后缘）均高于对照组；对照组并发症累积发生率为51.72%(30/58)，高于观察组的26.67%(16/60)（

http://html.publish.founderss.cn/rc-pub/api/common/picture?pictureId=5210285&type=

http://html.publish.founderss.cn/rc-pub/api/common/picture?pictureId=5210283&type=

2.96333337

3.13266659

＝7.784

，P

0.01）；术后24，48周观察组BGP水平均高于对照组，BALP，TRAP-5b，PICP，

-CTX和

-MID-OT均低于对照组（

0.01）；未发现口服金匮肾气丸有相关不良反应。

结论

金匮肾气丸加减结合骨折三期辨证用于OVCF微创手术后患者，近期可减轻腰背疼痛等症状，促进腰椎功能的恢复，综合疗效显著，远期可改善责任椎体强度，恢复伤椎解剖结构，并能增加椎体的骨密度，进一步改善腰椎功能，降低并发症的发生，还可调节骨代谢标志物，起到改善骨质疏松的效果。

Abstract

Objective

To evaluate the short-term and long-term efficacy of Jingui Shenqiwan combined with three-stage syndrome differentiation on osteoporotic vertebral compression fractures (OVCFs) after operation

and its regulatory effect on biomarkers of bone metabolism.

Method

One hundred and thirty-five patients were randomly divided into control group (67 cases) and observation group (68 cases) by random number table. A total of 58 patients in control group completed the treatment (4 patients were exfoliated

2 patients were lost to follow-up

3 patients were eliminated); and 60 patients in observation group completed the treatment (3 patients were exfoliated

2 patients were lost to follow-up

3 patients were eliminated). Both groups patients were given calcitonin injection through intramuscular injection

20 u/time

1 time/week

for 12 weeks

calcium carbonate D3 chewable tablets (Ⅱ)

1 tablet/time

2 times/day

and alendronate sodium tablets

70 mg/time

1 time/week. Patients in control group got Bushen Jiangu capsule

4 grains/time

3 times/day. And patients in observation group got modified Jingui Shenqiwan combined with fracture three-stage symptom differentiation

1 dose/day. The courses of treatment in the two groups were 24 weeks

and a 24 week follow-up was provided. Before the operation and at the 12

and 24

week after operation

the short-term efficacy indexes

such as back pain

lumbar function

traditional Chinese medicine （TCM） syndromes and complications

were recorded. And the long-term efficacy indexes

such as recovery of responsible vertebral body

lumbar function

bone density and quality of life and incidence of 48 week re-fracture

were also recorded. Before and after operation

levels of bone alkaline phosphatase (BALP)

osteocalcin (BGP)

tartrate resistant acid phosphatase-5b (TRAP-5b)

type I collagen carboxy terminal prepeptide (PICP)

type I collagen cross-linked C-terminal peptide (

-CTX) and

-MID-OT were detected

and the safety was evaluated.

Result

The comprehensive efficacy in observation group was superior to that in control group (

=2.026

0.05). At the 12

and 24

week after operation

scores of back pain

lumbar function and TCM syndromes were all lower than those in control group (

0.01)

and score of lumbar function at the 48

week after operation was also lower than that in control group (

0.01). Bone density was higher than that in control group at the 24

and 48

week after operation

and score of quality of life was lower than that in control group (

0.01). At the 24

and 48

week after operation

Cobb angles were less than those in control group

and heights of responsible centrums (anterior

central

posterior) were higher than those in control group. Cumulative incidence of complications in control group was 51.72% (30/58)

which was higher than 26.67% (16/60) in control group (

http://html.publish.founderss.cn/rc-pub/api/common/picture?pictureId=5210289&type=

http://html.publish.founderss.cn/rc-pub/api/common/picture?pictureId=5210287&type=

3.30199981

3.64066648

=7.784

0.01). The levels of BGP were higher than those in observation group at the 24

and 48

week after operation

and the levels of BALP

TRAP-5b

PICP

-CTX and

-MID-OT were all lower than those in control group (

0.01). And there was no side effect relating to Jingui Shenqiwan.

Conclusion

Modified Jingui Shenqiwan combined with fracture three-stage symptom differentiation can reduce the symptoms of back pain and promote the recovery of lumbar function

with a significant short-term comprehensive efficacy. In the long term

it can improve the strength of responsible centrums

restore the anatomical structure of injured centrums

increase the bone density of centrums

further improve the lumbar function

reduce the occurrence of complications

regulate the markers of bone metabolism

and improve osteoporosis.

关键词

Keywords

references

中华医学会骨质疏松和骨矿盐疾病分会 . 原发性骨质疏松症诊疗指南(2017) [J]. 中华骨质疏松和骨矿盐疾病杂志 , 2017 , 10 ( 5 ): 413 - 443 .

中华医学会骨质疏松和骨矿盐疾病分会 . 骨质疏松性椎体压缩性骨折诊疗与管理专家共识 [J]. 中华骨质疏松和骨矿盐疾病杂志 , 2018 , 11 ( 5 ): 425 - 437 .

赵海玲 , 周宗波 , 李建强 , 等 . 加味补肾活血汤联合中药熏蒸治疗骨质疏松性椎体压缩性骨折术后患者的临床观察 [J]. 中国实验方剂学杂志 , 2019 , 25 ( 8 ): 95 - 100 .

张威 , 朱立国 , 李学朋 , 等 . 五点支撑功能锻炼对骨质疏松性椎体压缩性骨折PKP术后患者后凸畸形及功能恢复的影响 [J]. 北京中医药 , 2019 , 38 ( 3 ): 267 - 269 .

张洁文 , 冯绍文 , 陈少珍 . 健骨汤辅助治疗对骨质疏松性胸腰椎压缩性骨折患者椎体成形术后骨折愈合的影响 [J]. 中药材 , 2017 , 40 ( 8 ): 1972 - 1974 .

徐绍俊 , 黄建烽 , 邵敏 , 等 . 补肾方剂对绝经后骨质疏松症大鼠的影响及其作用机制研究 [J]. 中药新药与临床药理 , 2017 , 28 ( 5 ): 588 - 593 .

王建伟 , 马勇 , 张亚峰 , 等 . 金匮肾气丸联用葡萄糖酸钙治疗原发性骨质疏松症的临床研究 [J]. 中国骨质疏松杂志 , 2011 , 17 ( 10 ): 911,912 - 914 .

中国老年学学会骨质疏松委员会中医药与骨病学科组 . 中医药防治原发性骨质疏松症专家共识(2015) [J]. 中国骨质疏松杂志 , 2015 , 21 ( 9 ): 1023 - 1028 .

刘志雄．骨科常见诊断分类方法和功能结果评定标准 [M]. 北京 : 科学技术出版社， 2005 : 335 - 336 .

中华医学会骨科学分会骨质疏松学组 . 骨质疏松性骨折诊疗指南 [J]. 中华骨科杂志 , 2017 , 37 ( 1 ): 1 - 10 .

李延红 , 龚福太 , 石耀武 , 等 . 原发性骨质疏松症中西医结合治疗现状及研究进展 [J]. 中国骨质疏松杂志 , 2017 , 23 ( 5 ): 690 - 694 .

孙铁锋 , 李振华 . 对国医大师刘柏龄治疗骨痿症的验案探析 [J]. 当代医药论丛 , 2015 , 13 ( 21 ): 250 - 251 .

CALCIOLARI E , MARDAS N , DEREKA X , et al . The effect of experimental osteoporosis on bone regeneration: part 2, proteomics results [J]. Clin Oral Implants Res , 2017 , 28 ( 9 ): 135 - 145 .

KIM B J , YOO H J , PARK S J , et al . Association of blood n-3 fatty acid with bone mass and bone marrow TRAP-5b in the elderly with and without hip fracture [J]. Osteoporos Int , 2019 , 30 ( 5 ): 1071 - 1078 .

ZHANG Y , FENG E , XU Y , et al . Serum Sema4D levels are associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis [J]. Int J Clin Exp Med ， 2015 , 8 ( 9 ): 16352 - 16357 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Observation of Jiawei Bushen Huoxuetang Combined with Fumigation of Traditional Chinese Medicine After Operation of Vertebral Compression Fracture

Pathways Related to Osteoporosis Treatment with Active Ingredients of Scutellaria Baicalensis： A Review

Research Progress on Pathogenesis of Osteoporosis and Intervention of Traditional Chinese Medicine： A Review

Corylin in Treatment of Metabolic Bone Diseases： A Review

Clinical Efficacy and Mechanism of Modified Erxian Decoction in Treating Osteoporosis with Yang Deficiency

Related Author

Hai-ling ZHAO

Zong-bo ZHOU

Jian-qiang LI

Jian HUANG

Yi CHENG

Zhi-fu LU

DU Jianqiang

QIN Wenxiu

Related Institution

Haikou Hospital of Traditional Chinese Medicine

Tianjin University of Traditional Chinese Medicine（TCM）

The Second Affiliated Hospital of Tianjin University of TCM

Gansu University of Chinese Medicine

Binhai New Area Hospital of TCM（Fourth Teaching Hospital of Tianjin University of TCM）

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰